Skip to main content

Design of polyPEPTIdes diblock copolymers as emulsifiers to produce safe, controlled and reliable novel stimuli-responsive nanoCAPSules for skin care applications

Objective

PeptiCaps aims at producing and validating a new family of stimuli-responsive nanocapsules able to encapsulate efficiently and protect specific active ingredients for skin care application. Those nanocapsules will be assembled by nanoemulsion technique using amphiphilic and biocompatible polypeptides diblock copolymers with one hydrophilic poly(ethylene glycol) block and one hydrophobic polypeptide block. Adjustment of the length of each block to finely tune the hydrophilic/Lipophilic balance of the macroemulsifier will allow the encapsulation of either hydrophobic or hydrophilic active ingredients. In addition, polypeptides block will be specifically designed to respond to changes in pH and the presence of enzyme occurring for the skin conditions targeted to allow a triggered release of the active ingredient. After scaling-up selected macroemulsifiers under GMP-like process, two manufacturing processes will be used for the production of the nanocapsules, i.e. high-pressure homogenizer and tubular flow contactor. The most promising process will be selected to produce selected nanocapsules. Physico-chemical properties and (eco)toxicity of the nanocapsules will be extensively characterised using techniques and protocols recommended by the EU Cosmetic regulation to establish their risk and safety assessment. The advantages of safe nanocapsules from PeptiCaps will be demonstrated on validated relevant skin models for each application. All results obtained will be gathered to constitute a Dossier for the validation of the nanocapsules as cosmetic product by the authorities. In addition, PeptiCaps will actively participate to the standardization for nano-safety by developing software to predict the toxicity of nanomaterials (CORAL). Finally, a business plan will be elaborated for the commercialization of PeptiCaps nanocapsules for all cosmetic applications as well as other markets (dermatology and food) to ensure full exploitation of the PeptiCaps technology.

Field of science

  • /social sciences/economics and business/business and management/commerce
  • /natural sciences/computer and information sciences/software
  • /social sciences/economics and business
  • /medical and health sciences/clinical medicine/dermatology
  • /natural sciences/biological sciences/biochemistry/biomolecules/proteins/enzymes
  • /engineering and technology/nanotechnology/nano-materials

Call for proposal

H2020-NMP-PILOTS-2015
See other projects for this call

Funding Scheme

RIA - Research and Innovation action

Coordinator

FUNDACION CIDETEC
Address
Paseo Miramon 196 Parque Tecnologico De Miramon
20014 San Sebastian
Spain
Activity type
Research Organisations
EU contribution
€ 895 000

Participants (8)

UNIVERSITE DE BORDEAUX
France
EU contribution
€ 417 278,75
Address
Place Pey Berland 35
33000 Bordeaux
Activity type
Higher or Secondary Education Establishments
UNIVERSIDAD DEL PAIS VASCO/ EUSKAL HERRIKO UNIBERTSITATEA
Spain
EU contribution
€ 460 656,25
Address
Barrio Sarriena S N
48940 Leioa
Activity type
Higher or Secondary Education Establishments
AHAVA DEAD SEA LABORATORIES LTD
Israel
EU contribution
€ 371 522,50
Address
Arava Street 1
70150 Airport City
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
POLYPEPTIDE THERAPEUTIC SOLUTIONS SOCIEDAD LIMITADA
Spain
EU contribution
€ 482 875
Address
Parque Tecnologico Calle Benjamin Franklin 19
46980 Valencia
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
UNIVERSITE LYON 1 CLAUDE BERNARD
France
EU contribution
€ 419 093,75
Address
Boulevard Du 11 Novembre 1918 Num43
69622 Villeurbanne Cedex
Activity type
Higher or Secondary Education Establishments
ANGEL CONSULTING SAS DI MATTEO ZANOTTI RUSSO & C
Italy
EU contribution
€ 147 500
Address
Via San Senatore 14
20122 Milano
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI
Italy
EU contribution
€ 435 500
Address
Via Mario Negri 2
20156 Milano
Activity type
Research Organisations
SPINVERSE OY
Finland
EU contribution
€ 222 867,50
Address
Tekniikantie 14
02150 Espoo
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)